Filtros : "RSC Advances" "PLANEJAMENTO DE FÁRMACOS" Limpar

Filtros



Refine with date range


  • Source: RSC Advances. Unidade: IFSC

    Subjects: NEOPLASIAS MAMÁRIAS, ANTINEOPLÁSICOS, PLANEJAMENTO DE FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Thiago Sabino da et al. Discovery of indolizine lactones as anticancer agents and their optimization through late-stage functionalization. RSC Advances, v. 2023, n. 29, p. 20264-20270 + supplementary information: 1-128, 2023Tradução . . Disponível em: https://doi.org/10.1039/d3ra03395c. Acesso em: 27 nov. 2025.
    • APA

      Silva, T. S. da, Souza, M. da S., Andricopulo, A. D., & Coelho, F. A. S. (2023). Discovery of indolizine lactones as anticancer agents and their optimization through late-stage functionalization. RSC Advances, 2023( 29), 20264-20270 + supplementary information: 1-128. doi:10.1039/d3ra03395c
    • NLM

      Silva TS da, Souza M da S, Andricopulo AD, Coelho FAS. Discovery of indolizine lactones as anticancer agents and their optimization through late-stage functionalization [Internet]. RSC Advances. 2023 ; 2023( 29): 20264-20270 + supplementary information: 1-128.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1039/d3ra03395c
    • Vancouver

      Silva TS da, Souza M da S, Andricopulo AD, Coelho FAS. Discovery of indolizine lactones as anticancer agents and their optimization through late-stage functionalization [Internet]. RSC Advances. 2023 ; 2023( 29): 20264-20270 + supplementary information: 1-128.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1039/d3ra03395c
  • Source: RSC Advances. Unidades: IFSC, IQSC

    Subjects: CRISTALOGRAFIA, HIPERGLICEMIA, PLANEJAMENTO DE FÁRMACOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VILLAMIZAR-DELGADO, Stephanny et al. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment. RSC Advances, v. 10, n. 38, p. 22856-22863, 2020Tradução . . Disponível em: https://doi.org/10.1039/d0ra04059b. Acesso em: 27 nov. 2025.
    • APA

      Villamizar-Delgado, S., Porras-Osorio, L. M., Piñeros, O., Ellena, J., Balcazar, N., Varela-Miranda, R. E., & D'Vries, R. F. (2020). Biguanide-transition metals complexes as potential drug for hyperglycemia treatment. RSC Advances, 10( 38), 22856-22863. doi:10.1039/d0ra04059b
    • NLM

      Villamizar-Delgado S, Porras-Osorio LM, Piñeros O, Ellena J, Balcazar N, Varela-Miranda RE, D'Vries RF. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment [Internet]. RSC Advances. 2020 ; 10( 38): 22856-22863.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1039/d0ra04059b
    • Vancouver

      Villamizar-Delgado S, Porras-Osorio LM, Piñeros O, Ellena J, Balcazar N, Varela-Miranda RE, D'Vries RF. Biguanide-transition metals complexes as potential drug for hyperglycemia treatment [Internet]. RSC Advances. 2020 ; 10( 38): 22856-22863.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1039/d0ra04059b

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025